๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Guangzhou
Clinical trial register · China

Clinical Trials in Guangzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University451 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University181 Nanfang Hospital, Southern Medical University138 AstraZeneca133 Guangdong Provincial People's Hospital81
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Guangzhou

3318 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Safety and Efficacy of Pucotenlimab in pLECC
NCT06969534Lymphoepithelioma-like Carcinoma, Lymphoepithelioma, Carcinoma
Sun Yat-sen University
Phase 2
33
Guangzhou
2025-05-15
Recruiting
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
NCT06925737Prostate Cancer, Prostatic Neoplasms
Merck Sharp & Dohme LLC
Phase 3
1,440
Beijing, Chongqing, Fuzhou, Guangzhou, Zhuhai, Nanning, Zhengzhou, Wuhan
2025-05-13
Active, closed
A Study Evaluating the Pharmacokinetics, Safety, and Efficacy of Cevostamab in Chinese Participants With Relapsed or Refractory Multiple Myeloma
NCT06934044Multiple Myeloma
Hoffmann-La Roche
Phase 1
20
Guangzhou, Tianjin, Nanchang, Wenzhou, Wuhan
2025-05-13
Recruiting
A Study of ZL-1310 in Participants With Selected Solid Tumors
NCT06885281Solid Tumors
Zai Lab (Shanghai) Co., Ltd.
Phase 1/2
166
Beijing, Xiamen, Guangzhou, Harbin, Changsha, Changchun, Shanghai
2025-05-12
Recruiting
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
NCT06819891Moderately to Severely Active Crohns Disease
Hoffmann-La Roche
Phase 3
425
Ganzhou, Kunming, Jinhua, Beijing, Chengdu, Guangzhou, Haikou, Huizhou
2025-05-12
Active, closed
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-031/LIGHTRAY EXTENSION)
NCT06925750Pulmonary Arterial Hypertension
Merck Sharp & Dohme LLC
Phase 2
130
Guangzhou, Changsha, Shanghai, Kunming
2025-05-12
Recruiting
PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC
NCT06977074Non-small Cell Lung Cancer (NSCLC)
Sun Yat-sen University
Phase 2
83
Guangzhou
2025-05-10
Recruiting
Risk Assessment for HBV-Related Liver Cancer
NCT07160946HBV-related Liver Cirrhosis
Sun Yat-sen University
Observational
6,000
Guangzhou
2025-05-10
Recruiting
ICP-332 in Subjects With Non-segmental Vitiligo
NCT07047612Non Segmental Vitiligo
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 2/3
603
Wuhu, Beijing, Chongqing, Fuzhou, Guangzhou, Shijiazhuang, Luoyang, Nanyang
2025-05-09
Recruiting
A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients
NCT06911827Advanced Solid Tumor
Qilu Pharmaceutical Co., Ltd.
Phase 1/2
149
Guangzhou
2025-05-09
Recruiting
Immediate Angioplasty For Acute Ischemic Stroke With Severe Intracranial Atherosclerotic Stenosis
NCT06437600Stroke, Acute Ischemic
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
412
Guangzhou, Shenzhen
2025-05-08
Recruiting
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
NCT06935357Immunoglobulin A Nephropathy (IgAN)
Biogen
Phase 3
454
Fuyang, Hefei, Beijing, Fuzhou, Xiamen, Lanzhou, Guangzhou, Shenzhen
2025-05-08
Not yet open
Aspirin 150 mg vs 100 mg for Prevention of Preeclampsia in High-Risk Obese Pregnant Women
NCT06952712Preeclampsia
FANG HE
Phase 3
1,300
Guangzhou
2025-05-07
Recruiting
Crisugabalin for Radiotherapy-Related Neuropathic Pain
NCT06766916Neuropathic Pain
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
172
Fuzhou, Guangzhou, Zhongshan, Nanning, Zhengzhou, Changsha
2025-05-07
Active, closed
Phase I Trial of QH-1A Hybrid Bio-Artificial Liver With Ex Vivo Blood-Purifying MSCs in Acute-on-Chronic Liver Failure
NCT06996392Acute-On-Chronic Liver Failure
Third Affiliated Hospital, Sun Yat-Sen University
Phase 1
15
Guangzhou
2025-05-07
Recruiting
A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
NCT06952699Narcolepsy Type 2
Takeda
Phase 2
88
Beijing, Guangzhou, Changchun, Shanghai
2025-05-06
Not yet open
Chemoimmunotherapy With or Without SBRT Before Surgery for Locally Advanced Oral and Oropharyngeal Cancer
NCT06861712Oral Squamous Cell Carcinoma (OSCC), Oropharyngeal Squamous Cell Carcinoma (SCC), Stereotactic Body Radiation Therapy (SBRT)
Sun Yat-sen University
Phase 2
50
Guangzhou
2025-05-06
Recruiting
Safety and Efficacy of Exercise in Type-B Aortic Dissection
NCT07009067Type B Aortic Dissection
Guangdong Provincial People's Hospital
Not applicable
20
Guangzhou
2025-05-06
Recruiting
A Study of MRG003 in Combination With Pucotenlimab Versus Chemotherapy in the Treatment of Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
NCT06976190Recurrent or Metastatic Nasopharyngeal Carcinoma
Lepu Biopharma Co., Ltd.
Phase 3
446
Guangzhou
2025-05-06
Recruiting
QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.
NCT06749899Nasopharyngeal Cancinoma (NPC), Nasopharyngeal Cancer
Sun Yat-Sen University Cancer Center
Phase 3
580
Fuzhou, Dongguan, Foshan, Guangzhou, Zhongshan, Nanning, Guiyang, Wuhan
2025-05-04
Recruiting
Comparison of TAF and TDF in Preventing Mother-to-Child Transmission of HBV in Pregnancies With High Viral Loads
NCT06947356Hepatitis B
Guangzhou 8th People's Hospital
Not applicable
210
Guangzhou, Shenzhen, Shijiazhuang, Changsha, Wenzhou, Beijing
2025-05-03
Recruiting
CHina Adrenal Venous saMPling InvestigatiON
NCT07252284Hyperaldosteronism, Adrenal Venous Sampling, Adrenalectomy
Chinese Academy of Medical Sciences, Fuwai Hospital
Observational
5,000
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Foshan, Guangzhou
2025-05-01
Recruiting
Efficacy and Safety of rTMS Combined With HA in the Treatment of Cognitive Decline in Aged Related Hearing Loss
NCT07389213Senile Deadness
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
189
Guangzhou
2025-05-01
Recruiting
Chimeric Antigen Receptors T Cells for Refractory/Recurrent Lupus Nephritis in Children
NCT06904729Lupus Nephritis
Guangzhou Women and Children's Medical Center
Phase 3
50
Guangzhou
2025-05-01
Recruiting
An AI Educational Agent for Medical Machine Learning Courses
NCT07449182Medical Education, Artificial Intelligence in Medicine
Sun Yat-sen University
Not applicable
56
Guangzhou
2025-05-01
Recruiting
Node-Sparing Short-Course Radiotherapy Plus Chemotherapy, Bevacizumab and PD-1 Inhibitor in Metastatic pMMR/MSS Colorectal Cancer (MODIFI-CRC)
NCT06958419Immune Checkpoint Therapy, Radiotherapy, Metastatic Colorectal Cancer (CRC)
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2/3
286
Guangzhou
2025-05-01
Recruiting
Node-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for Mid/Low pMMR/MSS Rectal Cancer (MODIFI-RC-II)
NCT06958432Rectal Cancer, Neoadjuvant Therapies, Immune Checkpoint Therapy, Radiotherapy
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2/3
430
Guangzhou
2025-05-01
Recruiting
The Impact of Breathing Training on PPSUI: A Randomized Controlled Trial
NCT06623617Stress Urinary Incontinence (SUI)
Jie Li
Not applicable
58
Guangzhou
2025-05-01
Recruiting
Short-course Radiotherapy Followed by Sequential Chemotherapy With or Without PD-1 Monoclonal Antibody and Bevacizumab as Total Neoadjuvant Therapy in pMMR/MSS Locally Advanced Rectal Cancer ๏ผˆSPARK๏ผ‰
NCT07005570pMMR/MSS Locally Advanced Rectal Cancer
Dechang Diao
Phase 2
86
Guangzhou
2025-05-01
Not yet open
Anlotinib Combined With Benmelstobart for Advanced Pheochromocytoma
NCT06429397Pheochromocytoma
Sun Yat-sen University
Phase 2
22
Guangzhou
2025-05-01
Not yet open
China Chronic Cough Registry: a Multicenter, Prospective, Observational Study
NCT06862362Chronic Cough (CC)
The First Affiliated Hospital of Guangzhou Medical University
Observational
6,000
Guangzhou
2025-05-01
Recruiting
The Impact of MTM Model on the Efficacy and Safety of Anticoagulant Therapy in Postoperative Colorectal Cancer Patients
NCT06998745Thrombosis, Venous
Sixth Affiliated Hospital, Sun Yat-sen University
Not applicable
327
Guangzhou
2025-05-01
Not yet open
Laparoscopic Associating Liver Partition With Portal Vein Ligation for Staged Hepatectomy (ALPPS) for Colorectal Liver Metastases (CRLM)
NCT06779474Colorectal Liver Metastases
Yanhong Deng
Observational
30
Guangzhou
2025-05-01
Not yet open
Obinutuzumab With CHOP Versus Obinutuzumab With Bendamustine in the Treatment of Newly Diagnosed Follicular Lymphoma Grade 3A
NCT06961500Follicular Lymphoma Grade 3A
Sun Yat-sen University
Phase 2
133
Guangzhou
2025-05-01
Recruiting
Arsenic Trioxide With MAPK Inhibitors and Chemotherapy for Stage 4/M Neuroblastoma
NCT06933394Neuroblastoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
92
Guangzhou
2025-05-01
Not yet open
PD-1 Antibody Sintilimab Combined With Capecitabine as Adjuvant Therapy for High-Risk Nasopharyngeal Carcinoma
NCT06900218Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University
Phase 3
664
Guangzhou
2025-05-01
Not yet open
A Clinical Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Inhaled H057 in the Treatment of Acute Exacerbations of Bronchiectasis
NCT06958861Acute Exacerbations of Bronchiectasis
Shanghai Huilun Pharmaceutical Co., Ltd.
Phase 2
180
Fuyang, Hefei, Fuzhou, Guangzhou, Shenzhen, Baise City, Shijiazhuang, Nanyang
2025-05
Not yet open
An Interpretable Fundus Diseases Report Generating System Based On Weakly Labelings
NCT06918028Retinal Diseases, Choroidal Disease, Pathological Myopia, Diabetic Retinopathy
Zhongshan Ophthalmic Center, Sun Yat-sen University
Observational
9,999
Guangzhou
2025-05
Recruiting
Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy
NCT06862869Carcinoma, Non-Small-Cell Lung
Hoffmann-La Roche
Observational
800
Zhanjiang, Guangzhou, Kaifeng, Zhengzhou, รœrรผmqi, Beijing, Changsha, Changzhou
2025-04-30
Recruiting
Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to Treat Moderate to Severe Glabellar Lines
NCT06937944Moderate to Severe Glabellar Lines
JHM BioPharma (Tonghua) Co. , Ltd.
Phase 3
669
Beijing, Chongqing, Guangzhou, Shijiazhuang, Changsha, Xuzhou, Shanghai, Xianyang
2025-04-30
Recruiting
A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia
NCT06900920Primary Immune Thrombocytopenia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
199
Hefei, Wuhu, Beijing, Chongqing, Lanzhou, Guangzhou, Shenzhen, Zhanjiang
2025-04-30
Not yet open
Disitamab Vedotin Combined With Ivonescimab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
NCT06957561Bladder Cancer, Muscle-invasive Bladder Cancer
Sun Yat-sen University
Phase 1/2
30
Guangzhou
2025-04-30
Recruiting
Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR/MSS LARC.
NCT06911684Rectal Cancer Patients
Sun Yat-sen University
Phase 2
88
Guangzhou
2025-04-30
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
NCT06884618Neoplasms
Hoffmann-La Roche
Phase 1
405
Guangzhou, Shanghai, Wuhan
2025-04-30
Recruiting
Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy
NCT06817265Non-Proliferative Diabetic Retinopathy
Beletalent (Zhuhai) Pharmaceutical Co., Ltd
Phase 3
360
Xuancheng, Beijing, Guangzhou, Shenzhen, Zhuhai, Guiyang, Shijiazhuang, Kaifeng
2025-04-29
Recruiting
Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors
NCT06963281Solid Tumors
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
Phase 1
285
Guangzhou, Jinan, Taiyuan
2025-04-29
Recruiting
The Efficacy and Safety of Inpegsomatropin Injection in Children With Idiopathic Short Stature
NCT06927310Idiopathic Short Stature
Xiamen Amoytop Biotech Co., Ltd.
Phase 3
300
Hefei, Beijing, Chongqing, Xiamen, Lanzhou, Guangzhou, Zhengzhou, Wuhan
2025-04-28
Recruiting
Anlotinib + Benmelstobart + HAIC in Unresectable HCC: A Phase II Study
NCT07806292Unresectable Hepatocellular Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
30
Guangzhou
2025-04-28
Recruiting
Protein A immuNoaDsorption for the Treatment of Acute Episodes of Neuromyelitis Optica Spectrum Disorder
NCT06763848Neuromyelitis Optica Spectrum Disorders
Third Affiliated Hospital, Sun Yat-Sen University
Not applicable
144
Guangzhou
2025-04-25
Recruiting
Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma
NCT06970145Craniopharyngiomas
Nanfang Hospital, Southern Medical University
Phase 1/2
57
Guangzhou
2025-04-25
Recruiting
A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC
NCT06925516Intrahepatic Cholangiocarcinoma (Icc)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
38
Guangzhou
2025-04-25
Recruiting
Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors
NCT06414460Locally Advanced/Metastatic Solid Tumors
InSilico Medicine Hong Kong Limited
Phase 1/2
146
Beijing, Guangzhou, Nanjing, Shanghai
2025-04-25
Recruiting
A Phase I Study to Evaluate GFS202A in Advanced Solid Tumor Patients With Pre-cachexia or Cachexia
NCT06898255Cancer Cachexia
Genfleet Therapeutics (Shanghai) Inc.
Phase 1
36
Guangzhou
2025-04-24
Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
NCT06875310Carcinoma, Non-Small-Cell Lung
Mirati Therapeutics Inc.
Phase 3
630
Bengbu, Hefei, Beijing, Chongqing, Fuzhou Fujian, Xiamen, Guangzhou, Shantou
2025-04-24
By invitation
Tongmai Jiangtang Capsule for Cardiovascular Clinical Outcomes in High-Risk Metabolic Syndrome Patients
NCT06908473Metabolic Syndrome, Cardiovascular Disease (CKD), Cerebrovascular Disease, Qi Deficiency and Blood Stasis
Guangdong Provincial Hospital of Traditional Chinese Medicine
Phase 3
530
Guangzhou
2025-04-24
Recruiting
Correlation and Predictive Research of Metal Elements in Radiation-Induced Oral Mucositis
NCT06968520Head and Neck Tumors, Metal, Copper, Radiotherapy-Induced Oral Mucositis
Nanfang Hospital, Southern Medical University
Observational
383
Guangzhou
2025-04-24
Recruiting
Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis
NCT06880770Severe Hypertriglyceridemia
Arrowhead Pharmaceuticals
Phase 3
288
Beijing, Guangzhou, Guiyang, Harbin, Luoyang, Nanyang, Zhuzhou, Baotou
2025-04-24
Active, closed
Vorolanib Monotherapy or in Combination With Toripalimab as Adjuvant Therapy for Patients With Intermediate-high Risk of Recurrence in Renal Cell Carcinoma
NCT07047001Renal Cell Carcinoma (RCC), Adjuvant
Dong Wen
Phase 2
60
Guangzhou
2025-04-24
Recruiting
A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma
NCT06929624Diffuse Large B-cell Lymphoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
280
Beijing, Guangzhou
2025-04-24
Recruiting
Clinical Trial of TQB2825 Injection Combined Immunochemotherapy in Subjects With Diffuse Large B Cell Lymphoma
NCT06829771Diffuse Large B Cell Lymphoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2
90
Bengbu, Maโ€™anshan, Beijing, Fuzhou, Quanzhou, Lanzhou, Guangzhou, Liuzhou
2025-04-23
Recruiting
Effect of Exercise on Tapering Antipsychotics in Patients With Psycho-cardiological Disease(EXTRA-study)
NCT07025590Cardiovascular Diseases (CVD), Depression Anxiety Disorder
Guangdong Provincial People's Hospital
Not applicable
106
Guangzhou
2025-04-22
Active, closed
PCSK9 Inhibitor and PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy for pMMR/MSS Locally Advanced Rectal Cancer
NCT06933251Locally Advanced Rectal Cancer (LARC)
Guangdong Provincial People's Hospital
Phase 2
30
Guangzhou
2025-04-20
Recruiting
Postoperative EGFR-TKI Therapy forContralateral Pulmonary Nodules in Patients With EGFR-Mutant NSCLC๏ผˆARMOR2501๏ผ‰
NCT06924398Lung Cancer (NSCLC)
Sun Yat-sen University
Phase 2
32
Guangzhou
2025-04-20
Recruiting
A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma
NCT06860971Thyroid Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
144
Hefei, Beijing, Chongqing, Fuzhou, Lanzhou, Guangzhou, Gui'lin, Liuzhou
2025-04-18
Not yet open
GP Combined with Toripalimab Versus GP Induction Chemotherapy for Advanced Childhood Nasopharyngeal Carcinoma
NCT06605131Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University
Phase 2
72
Guangzhou
2025-04-17
Recruiting
Effectiveness of a Lifestyle Intervention for Pregnant Women With Abnormal Glucose Metabolism in Early Pregnancy: EAGM Trial
NCT06767722Early Pregnancy, Fasting Plasma Glucose, Hemoglobin A1c Protein, Human, Lifestyle Intervention
First Affiliated Hospital, Sun Yat-Sen University
Not applicable
3,430
Guangzhou
2025-04-16
Recruiting
A Study of HS-20122 in Patients With Advanced Solid Tumors
NCT06927570Advanced Solid Tumors
Hansoh BioMedical R&D Company
Phase 1
1,050
Guangzhou
2025-04-15
Active, closed
Chinese HCC Efficacy Evaluation, Response and Safety Study of TareSphere
NCT06900543Unresectable Hepatocellular Carcinoma
Chengdu New Radiomedicine Technology Co. LTD.
Phase 3
108
Fuzhou, Guangzhou, Zhengzhou, Wuhan, Nanjing, Shenyang, Xiโ€™an, Chengdu
2025-04-15
Recruiting
Electrical Impedance Tomography-Based Prognostic Model for ARDS
NCT06967207Acute Respiratory Distress Syndrome (ARDS), Ventilator-induced Lung Injury
XiaoJing Zou,MD
Observational
625
Guangzhou, Wuhan, Shanghai
2025-04-15
Active, closed
A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients
NCT06960889Esophageal Cancer (EsC)
Nanfang Hospital, Southern Medical University
Observational
500
Guangzhou
2025-04-15
Recruiting
Phase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma
NCT06827717Ewing Sarcoma
Sun Yat-sen University
Phase 2
29
Guangzhou
2025-04-15
Recruiting
Clinical Study on the Healing of Distal Radius Fractures With Conservative Treatment Assisted by Fu's Subcutaneous Needling
NCT07054463Distal Radius Fractures
Guangzhou University of Chinese Medicine
Not applicable
84
Guangzhou
2025-04-15
Recruiting
Nebulized MSC-Exos for Anti-MDA5+ RP-ILD: Safety and Efficacy Trial
NCT06919380Anti-MDA5 Positive Dermatomyositis-Associated RP-ILD, Rapidly Progressive Interstitial Lung Disease
Li Shiyue
Phase 1
10
Guangzhou
2025-04-15
Recruiting
Study on the Use of Lateral Decubitus Position in Left Breast Cancer Patients Undergoing Adjuvant Radiotherapy
NCT06902051Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Nanfang Hospital, Southern Medical University
Not applicable
86
Guangzhou
2025-04-14
Recruiting
Phase III Clinical Trial Evaluating the Resection Efficacy of 5-Aminolevulinic Acid Hydrochloride (5-ALA HCl) Fluorescence-Guided Microsurgery Versus Conventional White Light Microsurgery in Patients With Malignant Glioma (WHO Grade 3/4)
NCT061604925-aminolevulinic Acid, Fluorescence-guided Resection
Lee's Pharmaceutical Limited
Phase 3
144
Guangzhou, Zhengzhou
2025-04-14
Recruiting
Acalabrutinib Plus Rituximab for the Treatment of Elderly or Low- to Intermediate-Risk Younger Untreated Mantle Cell Lymphoma
NCT06846489Mantle Cell Lymphoma (MCL)
Sun Yat-sen University
Phase 2
50
Guangzhou
2025-04-14
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
NCT06858813Hepatocellular Cancer, Squamous-Cell Non-Small Cell Lung Cancer
AbbVie
Phase 1
232
Guangzhou, Shanghai
2025-04-14
Active, closed
Interventional Ablation for Early-stage Lung Cancer
NCT07005999Lung Cancer (NSCLC), Early Stage Lung Non-Small Cell Carcinoma
Guangzhou Institute of Respiratory Disease
Observational
656
Guangzhou
2025-04-12
Recruiting
Circulating Tumor DNA Guided Boost Therapy in Early Triple Negative Breast Patients With Residual Disease After Neoadjuvant Therapy
NCT06992336Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
411
Guangzhou
2025-04-10
Recruiting
A Study of KNT-0916 in Treatment of Unresectable or Metastatic Solid Tumors With FGFR2 Alterations
NCT06800196Solid Tumors With FGFR2 Alterations, Adult
KinoTeck Therapeutics Co., Ltd
Phase 1
151
Guangzhou
2025-04-10
Recruiting
SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases
NCT06794086Colorectal Cancer, Liver Metastases
Jun Huang
Phase 3
24
Guangzhou
2025-04-10
Recruiting
Modulating the Skin Microbiome to Prevent Radiation Dermatitis in Breast Cancer
NCT07066280Skin Microbiome, Breast Cancer, Radiation Dermatitis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3
326
Guangzhou
2025-04-10
Recruiting
The Electroencephalographic Mechanisms of Anesthesia and Human Consciousness
NCT07145697Consciousness, Level Altered
Guangzhou General Hospital of Guangzhou Military Command
Phase 4
30
Guangzhou
2025-04-10
Recruiting
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
NCT06790693Breast Cancer
Hoffmann-La Roche
Phase 3
450
Xiangyang, Beijing, Changsha, Chengdu, Guangzhou, Hangzhou, Harbin, Jiangmen
2025-04-09
Recruiting
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
NCT06822790Hypertriglyceridemia
Arrowhead Pharmaceuticals
Phase 3
869
Bengbu, Beijing, Guangzhou, Liuzhou, Xingtai, Luoyang, Changsha, Wuhan
2025-04-09
Recruiting
An Observational Study to Evaluate Effectiveness and Safety of Upadacitinib in Chinese Adult Participants With Moderate to Severely Active Ulcerative Colitis (UC)
NCT06838845Ulcerative Colitis
AbbVie
Observational
80
Guangzhou, Zhengzhou
2025-04-09
Recruiting
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
NCT05066217Lennox Gastaut Syndrome
Epygenix
Phase 3
260
Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Guiyang, Jinan
2025-04-09
Recruiting
Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgiTation and pErsistent Atrial Fibrillation: a Randomized Controlled Trial
NCT06883864Atrial Fibrillation (AF), Catheter Ablation, Atrial Functional Mitral Regurgitation
Beijing Anzhen Hospital
Not applicable
146
Hefei, Beijing, Xiamen, Guangzhou, Shijiazhuang, Harbin, Zhengzhou, Wuhan
2025-04-08
Recruiting
A Phase II Clinical Trial of Artificial Intelligence-assisted One-stop Radiotherapy for Breast Cancer After Breast-conserving Surgery
NCT06686459Breast Cancer Invasive
Sun Yat-sen University
Not applicable
860
Guangzhou
2025-04-06
Recruiting
Hypofractionated vs. Conventional Chemoradiotherapy After Induction Chemo-immunotherapy for Unresectable Esophageal Squamous Cell Carcinoma
NCT06912074Esophageal Squamous Cell Carcinoma (ESCC)
Sun Yat-sen University
Phase 2
134
Guangzhou
2025-04-05
Recruiting
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
NCT06801834Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Gilead Sciences
Phase 3
695
Beijing, Changchun, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin
2025-04-04
Recruiting
A Phase II Study of Toripalimab Combined With Sequential Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma
NCT06843889Locally Advanced Esophageal Squamous Cell Carcinoma
Nanfang Hospital, Southern Medical University
Phase 2
34
Guangzhou
2025-04-03
Recruiting
Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df
NCT07348302Rhinitis, Rhinoconjunctivitis
Inmunotek S.L.
Phase 3
736
Beijing, Guangzhou, Zhongshan, Xiangya, Changzhou, Qingdao, Shanghai, Tongji
2025-04-02
Recruiting
Evaluation of JSKN016 Combination Therapy in Subjects With NSCLC
NCT06868732Advanced Non-small Cell Lung Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 1
288
Guangzhou
2025-04-02
Recruiting
A Phase II Study to Evaluate HLX43 in Subjects With Recurrent/Metastatic Nasopharyngeal Carcinoma Failed or Intolerance to Second-line Therapy
NCT06839066Nasopharyngeal Carcinoma (NPC)
Shanghai Henlius Biotech
Phase 2
70
Fuzhou, Dongguan, Guangzhou, Shenzhen, Nanning, Guiyang, Wuhan, Changsha
2025-04-02
By invitation
Protective Effect of Ulinastatin and Thymosin ฮฑ1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA XI)
NCT06966687Aortic Dissection, Aortic Dissection Aneurysm
Nanjing Medical University
Not applicable
200
Beijing, Guangzhou, Shanghai, Chengdu
2025-04-01
Not yet open
MSC-EVs in Acute/ Acute-on-Chronic Liver Failure After Liver Transplantation
NCT06825572Liver Failure, Mesenchymal Stem Cell, Extracellular Vesicles
Third Affiliated Hospital, Sun Yat-Sen University
Phase 1
30
Guangzhou
2025-04-01
By invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
NCT06859099Polyneuropathy, Inflammatory Demyelinating, Chronic
Sanofi
Phase 3
300
Beijing, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Shanghai, Wuhan
2025-04-01
Not yet open
Liver Cancer Prognosis Investigation Study
NCT06623734Liver Neoplasms
Sun Yat-sen University
Observational
5,000
Guangzhou
2025-04-01
Recruiting
Icaritin in Combination With AG in Patients With Previously Untreated Advanced Pancreatic Ductal Adenocarcinoma
NCT06825546Advanced Pancreatic Ductal Adenocarcinoma
Sir Run Run Shaw Hospital
Phase 2
70
Guangzhou, Zhengzhou, Wuhan, Changsha, Hangzhou, Wenzhou
2025-04-01
Rows per page Showing 1201–1300 of 3318
Previous 11 12 13 14 15 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/guangzhou?page=13

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3,318 of those studies with a site in Guangzhou.

How many clinical trials are recruiting in Guangzhou?

1,972 of the 3,318 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 473 have not yet opened recruitment, 805 are active but closed to new participants, and 68 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.